Mifepristone 2.5, 5, 10mg versus placebo in the treatment of endometriosis

Josep Lluis Carbonell, Ana Marı́a Riverón, Yara Leonard, Jesús González, Braulio Heredia, Carlos Sánchez
In: Journal of Reproductive Health and Medicine · 2015 · vol. 2(1) , pp. 17–25 · doi:10.1016/j.jrhm.2015.09.001 · W2177311010
article OA: closed CC0 ⤵ 18 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated the efficacy and safety of mifepristone at doses of 2.5, 5, and 10mg compared to placebo for treating endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (35)

Cited by (18)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK